Contact this trialFirst, we need to learn more about you.
Chemotherapy
AZD0305 for Multiple Myeloma
Recruiting1 awardPhase 1 & 2
New York, New York
This trial tests AZD0305, a new drug, in patients with a type of cancer that hasn't responded to multiple treatments. The drug is given through an IV, and researchers will study its effects on the body and the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service